Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: Results of a survey of 66 cases in 24 Japanese institutes

Bone Marrow Transplantation

Volumn 19, Issue 5, 1997, Pages 461-466

  Kishi, K ^a   Takahashi, S ^b   Gondo, H ^c   Shiobara, S ^d   Kanamaru, A ^e   Kato, S ^f   Hirabayashi, N ^g   Moriyama, Y ^a   Harada, M ^h   Asano, S ^b   Hara, H ^e   Shibata, A ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

^f TOKAI UNIVERSITY   (Japan)

^g NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

Author keywords

Conditioning; GVHD; Leukemia; Regimen related toxicity; Second BMT

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; MELPHALAN;

ACUTE LYMPHOCYTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; DEATH; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOTHERAPY; JAPAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SIDE EFFECT; SURVIVAL RATE;

EID: 0031048358     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700680     Document Type: Article

References (16)

1. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994; 84: 3603-3612.
2. Kumar L. Leukemia: management of relapse after allogeneic bone marrow transplantation. J Clin Oncol 1994; 12: 1710-1717.
3. Frassoni F, Barrett AJ, Granena A et al. Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the EBMT of 117 cases. Br J Haematol 1988; 70: 317-320.
4. Arcese W, Goldman JM, D'Arcangelo E et al. Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Blood 1993; 82: 3211-3219.
5. Barrett AJ, Locatelli F, Treleaven JG et al. Second transplants for leukaemic relapse after bone marrow transplantation; high mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party. Br J Haematol 1991; 79: 567-574.
6. Wagner JE, Vogelsang GB, Zehnbauer BA et al. Relapse of leukemia after bone marrow transplantation: effect of second myeloablative therapy. Bone Marrow Transplant 1992; 9: 205-209.
7. Mrsic M, Horowitz MM, Atkinson K et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992; 9: 269-275.
8. Radich JP, Sanders JE, Buckner CD et al. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total body irradiation-containing regimens. J Clin Oncol 1993; 11: 304-313.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
10. Cox DR. Regression models and life tables. JR Stat Soc [B] 1972; 34: 187-220.
11. Gehan E. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965; 52: 203-224.
12. Mortimer J, Blinder MA, Schulman S et al. Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol 1989; 7: 50-57.
13. Weisdorf DJ, Woods WG, Nesbit ME et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia: risk factors and clinical outcome. Br J Haematol 1994; 86: 61-69.
14. Takahashi S, Okamoto SI, Shirafuji N et al. Recombinant human alycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transplant 1994; 13: 239-245.
15. Miyamura K, Tahara T, Tanimoto M et al. Long persistent bcr-ab1 positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. Blood 1993; 81: 1089-1093.
16. Hamon MD, Prentice HG, Gottleb DJ et al. Immunotherapy with interleukin-2 after ABMT in AML. Bone Marrow Transplant 1993; 11: 399-401.